Generic semaglutide could reshape diabetes drug coverage in Canada

Lower-cost medication dramatically improves the cost-effectiveness of treatment that helps prevent heart and kidney disease The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up to 2.1 million Canadians living with Type 2 diabetes who face a high risk of cardiovascular disease,…